Testing effectiveness (Phase 2)UnknownNCT05940545What this trial is testingUMIT-1 Trial Favipiravir & Ribavirin for the Treatment of CCHFWho this might be right forCCHF Liverpool School of Tropical Medicine 24
Early research (Phase 1)Looking for participantsNCT06799013What this trial is testingSafety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic FeverWho this might be right forVaccineCrimean-Congo Hemorrhagic Fever HDT Bio 48
Early research (Phase 1)Study completedNCT03020771What this trial is testingPhase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for HumansWho this might be right forCrimean-Congo Hemorrhagic Fever The Scientific and Technological Research Council of Turkey 60
Not applicableNot Yet RecruitingNCT06859619What this trial is testingSerological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne DiseasesWho this might be right forLeishmaniasisLeptospirosisBrucellosis+15 more University Hospital, Montpellier 183
Not applicableStudy completedNCT06894758What this trial is testingDevelopment of a Rapid Diagnostic Test to Identify Crimean-Congo Hemorrhagic Fever - Research and Development TestingWho this might be right forInfectious Diseases, Emerging Liverpool School of Tropical Medicine 196
Not applicableLooking for participantsNCT06624787What this trial is testingDevelopment Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-CareWho this might be right forCrimean-Congo Haemorrhagic Fever Liverpool School of Tropical Medicine 492
Not applicableTemporarily pausedNCT02483260What this trial is testingIntravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic FeverWho this might be right forViral Hemorrhagic Fever U.S. Army Medical Research and Development Command 30
Early research (Phase 1)Study completedNCT06684431What this trial is testingStudy to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic FeverWho this might be right forCrimean Congo Hemorrhagic Fever Karolinska Institutet 15
Testing effectiveness (Phase 2)WithdrawnNCT00992693What this trial is testingTreatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment FacilitiesWho this might be right forCrimean-Congo Hemorrhagic FeverLassa Fever U.S. Army Medical Research and Development Command
Testing effectiveness (Phase 2)Looking for participantsNCT06860334What this trial is testingUMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHFWho this might be right forCrimean-Congo Hemorrhagic Fever Liverpool School of Tropical Medicine 378